News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Edwards Lifesciences Corporation (EW) Comments On German Appellate Court Ruling


11/15/2013 10:15:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, CA--(Marketwired - Nov 14, 2013) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today said that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending the posting of a EUR 5 million bond by Medtronic. This action comes after the European Patent Office (EPO) issued a non-binding preliminary opinion in October indicating concerns about the validity of the Edwards Spenser patent.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Wired


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES